Cardiometabolic risk factors related to vitamin D and adiponectin in obese children and adolescents

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Kardas, Fatih ^a   Kendirci, Mustafa ^a   Kurtoglu, Selim ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D;

ADOLESCENT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); VITAMIN BLOOD LEVEL;

EID: 84881404108     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/503270     Document Type: Article

References (33)

1. Nadir M. A., Szwejkowski B. R., Witham M. D., Vitamin D and cardiovascular prevention. Cardiovascular Therapeutics 2010 28 4 e5 e12 2-s2.0-77954357811 10.1111/j.1755-5922.2010.00192.x
2. Melamed M. L., Michos E. D., Post W., Astor B., 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine 2008 168 15 1629 1637 2-s2.0-49449104636 10.1001/archinte.168.15.1629
3. Reis J. P., von Mühlen D., Miller E. R. III, Michos E. D., Appel L. J., Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009 124 3 e371 e379 2-s2.0-70349262530 10.1542/peds.2009-0213
4. Giovannucci E., Liu Y., Hollis B. W., Rimm E. B., 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine 2008 168 11 1174 1180 2-s2.0-45149090726 10.1001/archinte.168.11.1174 (Pubitemid 351831400)
5. Alemzadeh R., Kichler J., Babar G., Calhoun M., Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008 57 2 183 191 2-s2.0-38049092013 10.1016/j.metabol.2007.08.023
6. Forman J. P., Giovannucci E., Holmes M. D., Bischoff-Ferrari H. A., Tworoger S. S., Willett W. C., Curhan G. C., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007 49 5 1063 1069 2-s2.0-34247893803 10.1161/HYPERTENSIONAHA.107.087288 (Pubitemid 351664326)
7. Ukkola O., Santaniemi M., Adiponectin: a link between excess adiposity and associated comorbidities? Journal of Molecular Medicine 2002 80 11 696 702 2-s2.0-0036432925 10.1007/s00109-002-0378-7 (Pubitemid 35352035)
8. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I., Adiponectin and metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 29 33 2-s2.0-0345861775 10.1161/01.ATV.0000099786.99623.EF (Pubitemid 38082408)
9. Brambilla P., Antolini L., Street M. E., Adiponectin and hypertension in normal-weight and obese children. American Journal of Hypertension 2013 26 2 257 264
10. Ozturk A., Mazicioglu M. M., Hatipoglu N., Budak N., Keskin G., Yazlak Z., Balci N., Yildiz H., Yildiz K., Ustunbas H. B., Kurtoglu S., Reference body mass index curves for Turkish children 6 to 18 years of age. Journal of Pediatric Endocrinology and Metabolism 2008 21 9 827 836 2-s2.0-53849138694
11. Vaccaro O., Masulli M., Cuomo V., Rivellese A. A., Uusitupa M., Vessby B., Hermansen K., Tapsell L., Riccardi G., Comparative evaluation of simple indices of insulin resistance. Metabolism 2004 53 12 1522 1526 2-s2.0-9344256038 10.1016/j.metabol.2004.05.017 (Pubitemid 39556363)
12. Holick M. F., Medical progress: vitamin D deficiency. The New England Journal of Medicine 2007 357 3 266 281 2-s2.0-34447514029 10.1056/NEJMra070553 (Pubitemid 47080391)
13. Wortsman J., Matsuoka L. Y., Chen T. C., Lu Z., Holick M. F., Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition 2000 72 3 690 693 2-s2.0-0033847865 (Pubitemid 30667088)
14. Ashraf A., Alvarez J., Saenz K., Gower B., McCormick K., Franklin F., Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. Journal of Clinical Endocrinology and Metabolism 2009 94 9 3200 3206 2-s2.0-69949086117 10.1210/jc.2009-0445
15. Buffington C., Walker B., Cowan G. S. M. Jr., Scruggs D., Vitamin D deficiency in the morbidity obese. Obesity Surgery 1993 3 4 421 424 2-s2.0-0027135402 10.1381/096089293765559142 (Pubitemid 24014299)
16. Lenders C. M., Feldman H. A., von Scheven E., Merewood A., Sweeney C., Wilson D. M., Lee P. D. K., Abrams S. H., Gitelman S. E., Wertz M. S., Klish W. J., Taylor G. A., Chen T. C., Holick M. F., Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. American Journal of Clinical Nutrition 2009 90 3 459 467 2-s2.0-70349568152 10.3945/ajcn.2008.27275
17. Reis J. P., von Mühlen D., Miller E. R. III, Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. European Journal of Endocrinology 2008 159 1 41 48 2-s2.0-47049129714 10.1530/EJE-08-0072 (Pubitemid 351969129)
18. Hyppönen E., Boucher B. J., Berry D. J., Power C., 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age A cross-sectional study in the 1958 british birth cohort. Diabetes 2008 57 2 298 305 2-s2.0-40749094549 10.2337/db07-1122
19. Gannagé-Yared M.-H., Chedid R., Khalife S., Azzi E., Zoghbi F., Halaby G., Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. European Journal of Endocrinology 2009 160 6 965 971 2-s2.0-66149147830 10.1530/EJE-08-0952
20. Lind L., Hanni A., Lithell H., Hvarfner A., Sorensen O. H., Ljunghall S., Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. American Journal of Hypertension 1995 8 9 894 901 2-s2.0-0029156145 10.1016/0895-7061(95)00154-H
21. Reddy Vanga S., Good M., Howard P. A., Vacek J. L., Role of vitamin D in cardiovascular health. American Journal of Cardiology 2010 106 6 798 805 2-s2.0-77956338895 10.1016/j.amjcard.2010.04.042
22. Kelly A., Brooks L. J., Dougherty S., Carlow D. C., Zemel B. S., A cross-sectional study of vitamin D and insulin resistance in children. Archives of Disease in Childhood 2011 96 5 447 452 2-s2.0-79954596934 10.1136/adc.2010.187591
23. Greer R. M., Rogers M. A., Bowling F. G., Buntain H. M., Harris M., Leong G. M., Cotterill A. M., Australian children and adolescents with type 1 diabetes have low vitamin D levels. Medical Journal of Australia 2007 187 1 59 60 2-s2.0-34447512462 (Pubitemid 47082750)
24. Woodhouse P. R., Haw K.-T., Plummer M., Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. Journal of Hypertension 1993 11 11 1267 1274 2-s2.0-0027369402 (Pubitemid 23330085)
25. Melamed M. L., Astor B., Michos E. D., Hostetter T. H., Powe N. R., Muntner P., 25-Hydroxyvitamin D levels, race, and the progression of kidney disease. Journal of the American Society of Nephrology 2009 20 12 2631 2639 2-s2.0-72049115797 10.1681/ASN.2009030283
26. Li Y. C., Kong J., Wei M., Chen Z.-F., Liu S. Q., Cao L.-P., 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation 2002 110 2 229 238 2-s2.0-0036073755 10.1172/JCI200215219 (Pubitemid 34787360)
27. Florentin M., Elisaf M. S., Mikhailidis D. P., Liberopoulos E. N., Vitamin D and metabolic syndrome: is there a link? Current Pharmaceutical Design 2010 16 30 3417 3434 2-s2.0-78649810981 10.2174/138161210793563509
28. Sun X., Zemel M. B., Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity 2007 15 2 340 348 2-s2.0-33947152395 10.1038/oby.2007.540 (Pubitemid 46407314)
29. Cantorna M. T., Mahon B. D., D-hormone and the immune system. Journal of Rheumatology 2005 32 76 11 20 2-s2.0-24944512303 (Pubitemid 41324839)
30. Ruan H., Lodish H. F., Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor- α Cytokine and Growth Factor Reviews 2003 14 5 447 455 2-s2.0-0041374029 10.1016/S1359-6101(03)00052-2 (Pubitemid 37099456)
31. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., Kumada M., Okamoto Y., Nagaretani H., Nishizawa H., Kishida K., Komuro R., Ouchi N., Kihara S., Nagai R., Funahashi T., Matsuzawa Y., Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry 2002 277 40 37487 37491 2-s2.0-0037020170 10.1074/jbc.M206083200
32. Lindsay R. S., Funahashi T., Hanson R. L., Matsuzawa Y., Tanaka S., Tataranni P. A., Knowler W. C., Krakoff J., Adiponectin and development of type 2 diabetes in the Pima Indian population. The Lancet 2002 360 9326 57 58 2-s2.0-0037031088 10.1016/S0140-6736(02)09335-2 (Pubitemid 34756495)
33. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R. S., Youngren J. F., Havel P. J., Pratley R. E., Bogardus C., Antonio Tataranni P., Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002 51 6 1884 1888 2-s2.0-0036266897 (Pubitemid 34564302)